Warburg O On the origin of cancer cells Science 1956 123 309-314 
Frezza C Gottlieb E Mitochondria in cancer: not just innocent bystanders Semin Cancer Biol 2009 19 4-11 
Tennant DA Duran RV Gottlieb E Targeting metabolic transformation for cancer therapy Nat Rev Cancer 2010 10 267-277 
Kaelin WG Jr SDH5 mutations and familial paraganglioma: somewhere Warburg is smiling Cancer Cell 2009 16 180-182 
Frezza C Tennant DA Gottlieb E IDH1 mutations in gliomas: when an enzyme loses its grip Cancer Cell 2010 17 7-9 
Baysal BE Ferrell RE Willett-Brozick JE Lawrence EC Myssiorek D Bosch A Mey A Taschner PE Rubinstein WS Myers EN Richard CW 3rd Cornelisse CJ Devilee P Devlin B Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma Science 2000 287 848-851 
Niemann S Muller U Mutations in SDHC cause autosomal dominant paraganglioma, type 3 Nat Genet 2000 26 268-270 
Astuti D Latif F Dallol A Dahia PL Douglas F George E Skoldberg F Husebye ES Eng C Maher ER Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma Am J Hum Genet 2001 69 49-54 
Hao HX Khalimonchuk O Schraders M Dephoure N Bayley JP Kunst H Devilee P Cremers CW Schiffman JD Bentz BG Gygi SP Winge DR Kremer H Rutter J SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma Science 2009 325 1139-1142 
Bayley JP Kunst HP Cascon A Sampietro ML Gaal J Korpershoek E Hinojar-Gutierrez A Timmers HJ Hoefsloot LH Hermsen MA Suarez C Hussain AK Vriends AH Hes FJ Jansen JC Tops CM Corssmit EP Knijff P Lenders JW Cremers CW Devilee P Dinjens WN Krijger RR Robledo M SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma Lancet Oncol 2010 11 366-372 
Burnichon N Briere JJ Libe R Vescovo L Riviere J Tissier F Jouanno E Jeunemaitre X Benit P Tzagoloff A Rustin P Bertherat J Favier J Gimenez-Roqueplo AP SDHA is a tumor suppressor gene causing paraganglioma Hum Mol Genet 2010 19 3011-3020 
Housley SL Lindsay RS Young B McConachie M Mechan D Baty D Christie L Rahilly M Qureshi K Fleming S Renal carcinoma with giant mitochondria associated with germ-line mutation and somatic loss of the succinate dehydrogenase B gene Histopathology 2010 56 405-408 
Ricketts C Woodward ER Killick P Morris MR Astuti D Latif F Maher ER Germline SDHB mutations and familial renal cell carcinoma J Natl Cancer Inst 2008 100 1260-1262 
Henderson A Douglas F Perros P Morgan C Maher ER SDHB-associated renal oncocytoma suggests a broadening of the renal phenotype in hereditary paragangliomatosis Fam Can 2009 8 257-260 
Gottlieb E Tomlinson IP Mitochondrial tumour suppressors: a genetic and biochemical update Nat Rev Cancer 2005 5 857-866 
Nederveen FH Korpershoek E Lenders JW Krijger RR Dinjens WN Somatic SDHB mutation in an extraadrenal pheochromocytoma N Engl J Med 2007 357 306-308 
Stratakis CA Carney JA The triad of paragangliomas, gastric stromal tumours and pulmonary chondromas (Carney triad), and the dyad of paragangliomas and gastric stromal sarcomas (Carney&#8211;Stratakis syndrome): molecular genetics and clinical implications J Intern Med 2009 266 43-52 
Launonen V Vierimaa O Kiuru M Isola J Roth S Pukkala E Sistonen P Herva R Aaltonen LA Inherited susceptibility to uterine leiomyomas and renal cell cancer Proc Natl Acad Sci USA 2001 98 3387-3392 
Tomlinson IP Alam NA Rowan AJ Barclay E Jaeger EE Kelsell D Leigh I Gorman P Lamlum H Rahman S Roylance RR Olpin S Bevan S Barker K Hearle N Houlston RS Kiuru M Lehtonen R Karhu A Vilkki S Laiho P Eklund C Vierimaa O Aittomaki K Hietala M Sistonen P Paetau A Salovaara R Herva R Launonen V Aaltonen LA Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer Nat Genet 2002 30 406-410 
Carvajal-Carmona LG Alam NA Pollard PJ Jones AM Barclay E Wortham N Pignatelli M Freeman A Pomplun S Ellis I Poulsom R El-Bahrawy MA Berney DM Tomlinson IP Adult leydig cell tumors of the testis caused by germline fumarate hydratase mutations J Clin Endocrinol Metab 2006 91 3071-3075 
Lehtonen HJ Kiuru M Ylisaukko-Oja SK Salovaara R Herva R Koivisto PA Vierimaa O Aittomaki K Pukkala E Launonen V Aaltonen LA Increased risk of cancer in patients with fumarate hydratase germline mutation J Med Genet 2006 43 523-526 
Marcucci G Maharry K Wu YZ Radmacher MD Mrozek K Margeson D Holland KB Whitman SP Becker H Schwind S Metzeler KH Powell BL Carter TH Kolitz JE Wetzler M Carroll AJ Baer MR Caligiuri MA Larson RA Bloomfield CD IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study J Clin Oncol 2010 28 2348-2355 
Balss J Meyer J Mueller W Korshunov A Hartmann C Deimling A Analysis of the IDH1 codon 132 mutation in brain tumors Acta Neuropathol 2008 116 597-602 
Parsons DW Jones S Zhang X Lin JC Leary RJ Angenendt P Mankoo P Carter H Siu IM Gallia GL Olivi A McLendon R Rasheed BA Keir S Nikolskaya T Nikolsky Y Busam DA Tekleab H Diaz LA Jr Hartigan J Smith DR Strausberg RL Marie SK Shinjo SM Yan H Riggins GJ Bigner DD Karchin R Papadopoulos N Parmigiani G Vogelstein B Velculescu VE Kinzler KW An integrated genomic analysis of human glioblastoma multiforme Science 2008 321 1807-1812 
Bleeker FE Lamba S Leenstra S Troost D Hulsebos T Vandertop WP Frattini M Molinari F Knowles M Cerrato A Rodolfo M Scarpa A Felicioni L Buttitta F Malatesta S Marchetti A Bardelli A IDH1 mutations at residue p.R132 (IDH1R132) occur frequently in high-grade gliomas but not in other solid tumors Hum Mutat 2009 30 7-11 
Yan H Parsons DW Jin G McLendon R Rasheed BA Yuan W Kos I Batinic-Haberle I Jones S Riggins GJ Friedman H Friedman A Reardon D Herndon J Kinzler KW Velculescu VE Vogelstein B Bigner DD IDH1 and IDH2 mutations in gliomas N Engl J Med 2009 360 765-773 
Dang L White DW Gross S Bennett BD Bittinger MA Driggers EM Fantin VR Jang HG Jin S Keenan MC Marks KM Prins RM Ward PS Yen KE Liau LM Rabinowitz JD Cantley LC Thompson CB Vander Heiden MG Su SM Cancer-associated IDH1 mutations produce 2-hydroxyglutarate Nature 2009 462 739-744 
Gimenez-Roqueplo AP Favier J Rustin P Mourad JJ Plouin PF Corvol P Rotig A Jeunemaitre X The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway Am J Hum Genet 2001 69 1186-1197 
Dahia PL Ross KN Wright ME Hayashida CY Santagata S Barontini M Kung AL Sanso G Powers JF Tischler AS Hodin R Heitritter S Moore F Dluhy R Sosa JA Ocal IT Benn DE Marsh DJ Robinson BG Schneider K Garber J Arum SM Korbonits M Grossman A Pigny P Toledo SP Nose V Li C Stiles CD A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas PLoS Genet 2005 1 72-80 
Vanharanta S Pollard PJ Lehtonen HJ Laiho P Sjoberg J Leminen A Aittomaki K Arola J Kruhoffer M Orntoft TF Tomlinson IP Kiuru M Arango D Aaltonen LA Distinct expression profile in fumarate-hydratase-deficient uterine fibroids Hum Mol Genet 2006 15 97-103 
Cervera AM Apostolova N Crespo FL Mata M McCreath KJ Cells silenced for SDHB expression display characteristic features of the tumor phenotype Cancer Res 2008 68 4058-4067 
Ashrafian H O'Flaherty L Adam J Steeples V Chung YL East P Vanharanta S Lehtonen H Nye E Hatipoglu E Miranda M Howarth K Shukla D Troy H Griffiths J Spencer-Dene B Yusuf M Volpi E Maxwell PH Stamp G Poulsom R Pugh CW Costa B Bardella C Renzo MF Kotlikoff MI Launonen V Aaltonen L El-Bahrawy M Tomlinson I Pollard PJ Expression profiling in progressive stages of fumarate-hydratase deficiency: the contribution of metabolic changes to tumorigenesis Cancer Res 2010 70 9153-9165 
Selak MA Armour SM MacKenzie ED Boulahbel H Watson DG Mansfield KD Pan Y Simon MC Thompson CB Gottlieb E Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase Cancer Cell 2005 7 77-85 
Isaacs JS Jung YJ Mole DR Lee S Torres-Cabala C Chung YL Merino M Trepel J Zbar B Toro J Ratcliffe PJ Linehan WM Neckers L HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability Cancer Cell 2005 8 143-153 
Pollard PJ Briere JJ Alam NA Barwell J Barclay E Wortham NC Hunt T Mitchell M Olpin S Moat SJ Hargreaves IP Heales SJ Chung YL Griffiths JR Dalgleish A McGrath JA Gleeson MJ Hodgson SV Poulsom R Rustin P Tomlinson IP Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations Hum Mol Genet 2005 14 2231-2239 
Hewitson KS Lienard BM McDonough MA Clifton IJ Butler D Soares AS Oldham NJ McNeill LA Schofield CJ Structural and mechanistic studies on the inhibition of the hypoxia-inducible transcription factor hydroxylases by tricarboxylic acid cycle intermediates J Biol Chem 2007 282 3293-3301 
MacKenzie ED Selak MA Tennant DA Payne LJ Crosby S Frederiksen CM Watson DG Gottlieb E Cell-permeating alpha-ketoglutarate derivatives alleviate pseudohypoxia in succinate dehydrogenase-deficient cells Mol Cell Biol 2007 27 3282-3289 
Porcelli AM Ghelli A Ceccarelli C Lang M Cenacchi G Capristo M Pennisi LF Morra I Ciccarelli E Melcarne A Bartoletti-Stella A Salfi N Tallini G Martinuzzi A Carelli V Attimonelli M Rugolo M Romeo G Gasparre G The genetic and metabolic signature of oncocytic transformation implicates HIF1alpha destabilization Hum Mol Genet 2010 19 1019-1032 
Guzy RD Hoyos B Robin E Chen H Liu L Mansfield KD Simon MC Hammerling U Schumacker PT Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing Cell Metab 2005 1 401-408 
Mansfield KD Guzy RD Pan Y Young RM Cash TP Schumacker PT Simon MC Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF-alpha activation Cell Metab 2005 1 393-399 
Guzy RD Sharma B Bell E Chandel NS Schumacker PT Loss of the SdhB, but not the SdhA, subunit of complex II triggers ROS-dependent HIF activation and tumorigenesis Mol Cell Biol 2008 28 718-731 
Sudarshan S Sourbier C Kong HS Block K Valera Romero VA Yang Y Galindo C Mollapour M Scroggins B Goode N Lee MJ Gourlay CW Trepel J Linehan WM Neckers L Fumarate hydratase deficiency in renal cancer induces glycolytic addiction and hypoxia-inducible transcription factor 1alpha stabilization by glucose-dependent generation of reactive oxygen species Mol Cell Biol 2009 29 4080-4090 
Selak MA Duran RV Gottlieb E Redox stress is not essential for the pseudo-hypoxic phenotype of succinate dehydrogenase deficient cells Biochim Biophys Acta 2006 1757 567-572 
O'Flaherty L Adam J Heather LC Zhdanov AV Chung YL Miranda MX Croft J Olpin S Clarke K Pugh CW Griffiths J Papkovsky D Ashrafian H Ratcliffe PJ Pollard PJ Dysregulation of hypoxia pathways in fumarate hydratase-deficient cells is independent of defective mitochondrial metabolism Hum Mol Genet 2010 19 3844-3851 
Lee S Nakamura E Yang H Wei W Linggi MS Sajan MP Farese RV Freeman RS Carter BD Kaelin WG Jr Schlisio S Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer Cancer Cell 2005 8 155-167 
Schlisio S Kenchappa RS Vredeveld LC George RE Stewart R Greulich H Shahriari K Nguyen NV Pigny P Dahia PL Pomeroy SL Maris JM Look AT Meyerson M Peeper DS Carter BD Kaelin WG Jr The kinesin KIF1Bbeta acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor Genes Dev 2008 22 884-893 
Raimundo N Vanharanta S Aaltonen LA Hovatta I Suomalainen A Downregulation of SRF-FOS-JUNB pathway in fumarate hydratase deficiency and in uterine leiomyomas Oncogene 2009 28 1261-1273 
Schofield CJ Ratcliffe PJ Oxygen sensing by HIF hydroxylases Nat Rev Mol Cell Biol 2004 5 343-354 
Cervera AM Bayley JP Devilee P McCreath KJ Inhibition of succinate dehydrogenase dysregulates histone modification in mammalian cells Mol Cancer 2009 8 89 
Smith EH Janknecht R Maher LJ 3rd Succinate inhibition of alpha-ketoglutarate-dependent enzymes in a yeast model of paraganglioma Hum Mol Genet 2007 16 3136-3148 
Teperino R Schoonjans K Auwerx J Histone methyl transferases and demethylases; can they link metabolism and transcription? Cell Metab 2010 12 321-327 
Pollard PJ Loenarz C Mole DR McDonough MA Gleadle JM Schofield CJ Ratcliffe PJ Regulation of Jumonji-domain-containing histone demethylases by hypoxia-inducible factor (HIF)-1alpha Biochem J 2008 416 387-394 
Beyer S Kristensen MM Jensen KS Johansen JV Staller P The histone demethylases JMJD1A and JMJD2B are transcriptional targets of hypoxia-inducible factor HIF J Biol Chem 2008 283 36542-36552 
Yang J Jubb AM Pike L Buffa FM Turley H Baban D Leek R Gatter KC Ragoussis J Harris AL The histone demethylase JMJD2B is regulated by estrogen receptor alpha and hypoxia, and is a key mediator of estrogen induced growth Cancer Res 2010 70 6456-6466 
He W Miao FJ Lin DC Schwandner RT Wang Z Gao J Chen JL Tian H Ling L Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors Nature 2004 429 188-193 
Peti-Peterdi J High glucose and renin release: the role of succinate and GPR91 Kidney Int 2010 78 1214-1217 
Sapieha P Sirinyan M Hamel D Zaniolo K Joyal JS Cho JH Honore JC Kermorvant-Duchemin E Varma DR Tremblay S Leduc M Rihakova L Hardy P Klein WH Mu X Mamer O Lachapelle P Polo A Beausejour C Andelfinger G Mitchell G Sennlaub F Chemtob S The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis Nat Med 2008 14 1067-1076 
Tian Z Liu Y Usa K Mladinov D Fang Y Ding X Greene AS Cowley AW Jr Liang M Novel role of fumarate metabolism in dahl-salt sensitive hypertension Hypertension 2009 54 255-260 
Mardis ER Ding L Dooling DJ Larson DE McLellan MD Chen K Koboldt DC Fulton RS Delehaunty KD McGrath SD Fulton LA Locke DP Magrini VJ Abbott RM Vickery TL Reed JS Robinson JS Wylie T Smith SM Carmichael L Eldred JM Harris CC Walker J Peck JB Du F Dukes AF Sanderson GE Brummett AM Clark E McMichael JF Meyer RJ Schindler JK Pohl CS Wallis JW Shi X Lin L Schmidt H Tang Y Haipek C Wiechert ME Ivy JV Kalicki J Elliott G Ries RE Payton JE Westervelt P Tomasson MH Watson MA Baty J Heath S Shannon WD Nagarajan R Link DC Walter MJ Graubert TA DiPersio JF Wilson RK Ley TJ Recurring mutations found by sequencing an acute myeloid leukemia genome N Engl J Med 2009 361 1058-1066 
Gross S Cairns RA Minden MD Driggers EM Bittinger MA Jang HG Sasaki M Jin S Schenkein DP Su SM Dang L Fantin VR Mak TW Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations J Exp Med 2010 207 339-344 
Ward PS Patel J Wise DR Abdel-Wahab O Bennett BD Coller HA Cross JR Fantin VR Hedvat CV Perl AE Rabinowitz JD Carroll M Su SM Sharp KA Levine RL Thompson CB The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate Cancer Cell 2010 17 225-234 
Zhao S Lin Y Xu W Jiang W Zha Z Wang P Yu W Li Z Gong L Peng Y Ding J Lei Q Guan KL Xiong Y Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha Science 2009 324 261-265 
Pollard PJ Ratcliffe PJ Cancer. Puzzling patterns of predisposition Science 2009 324 192-194 
Figueroa ME Abdel-Wahab O Lu C Ward PS Patel J Shih A Li Y Bhagwat N Vasanthakumar A Fernandez HF Tallman MS Sun Z Wolniak K Peeters JK Liu W Choe SE Fantin VR Paietta E Lowenberg B Licht JD Godley LA Delwel R Valk PJ Thompson CB Levine RL Melnick A Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation Cancer Cell 2010 18 553-567 
